Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081805 | SCV000113740 | benign | not specified | 2012-07-18 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000081805 | SCV000269706 | benign | not specified | 2014-11-26 | criteria provided, single submitter | clinical testing | p.Lys227Lys in exon 8 of POMGNT1: This variant is not expected to have clinical significance because it has been identified in 35% (3000/8600) of European Ameri can chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington. edu/EVS/; dbSNP rs2292487). |
Prevention |
RCV000081805 | SCV000307105 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000304915 | SCV000357999 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2O | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000343385 | SCV000358000 | benign | Congenital Muscular Dystrophy, alpha-dystroglycan related | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Athena Diagnostics | RCV000576556 | SCV000677425 | benign | not provided | 2017-04-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001516894 | SCV001725260 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2O; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001533746 | SCV001750535 | benign | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001533747 | SCV001750536 | benign | Retinitis pigmentosa 76 | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000576556 | SCV001856491 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001789144 | SCV002031727 | benign | Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000304915 | SCV002031728 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2O | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003888448 | SCV004705233 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Breakthrough Genomics, |
RCV000576556 | SCV005284473 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000081805 | SCV000152348 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Natera, |
RCV001275750 | SCV001461199 | benign | Muscle eye brain disease | 2020-09-16 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000081805 | SCV001742742 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000081805 | SCV001917028 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000081805 | SCV001965806 | benign | not specified | no assertion criteria provided | clinical testing |